소장자료
LDR | 01770cam a2200385 a 4500 | ||
001 | 0093786367▲ | ||
005 | 20180521080220▲ | ||
008 | 170626s2017 enkac b 001 0 eng c▲ | ||
010 | ▼a2017946970▲ | ||
020 | ▼a9780128124390 (pbk.)▲ | ||
020 | ▼a0128124393 (pbk.)▲ | ||
035 | ▼a(KERIS)REF000018619330▲ | ||
040 | ▼aNLM▼beng▼cNLM▼dWSU▼dOCLCF▼dYDX▼dOCLCO▼dOCLCA▼dDLC▼d221016▲ | ||
042 | ▼apcc▲ | ||
050 | 0 | 0 | ▼aRM171.5▼b.H43 2017▲ |
060 | 0 | 0 | ▼a2017 H-025▲ |
060 | 1 | 0 | ▼aWH 11.1▲ |
082 | 0 | 4 | ▼a612.115▼223▲ |
090 | ▼a612.115▼bH455t▲ | ||
100 | 1 | ▼aHedner, U.▼q(Ulla)▲ | |
245 | 1 | 0 | ▼aTreating life-threatening bleedings :▼bdevelopment of recombinant coagulation factor VIIa /▼cUlla K. E. Hedner.▲ |
260 | ▼aLondon :▼bAcademic Press,▼c2017.▲ | ||
300 | ▼axiv, 199 p. :▼bill., ports. ;▼c23 cm.▲ | ||
504 | ▼aIncludes bibliographical references and index.▲ | ||
505 | 0 | ▼aClassical bleeding disease -- My encounter with hemophilia -- The first years at novo nordisk -- The development of recombinant FVIIa -- The futher use and development of rFVIIa -- Legal issues regarding the use of rFVIIa in hemophilia patients with inhibitors -- Treatment with rFVIIa in Malmö --Mechanism of action and dosage -- The continued development of rFVIIa during the 2000s -- Three different descriptions of how rFVIIa was developed -- Some final remarks.▲ | |
650 | 0 | ▼aBlood coagulation factors.▲ | |
650 | 0 | ▼aBlood coagulation factor VIII.▲ | |
650 | 0 | ▼aBlood coagulation disorders▼xTreatment.▲ | |
650 | 0 | ▼aHemophilia▼xTreatment.▲ | |
650 | 1 | 2 | ▼aFactor VIIa▼xhistory.▲ |
650 | 2 | 2 | ▼aBlood Coagulation Disorders▼xdrug therapy.▲ |
650 | 2 | 2 | ▼aRecombinant Proteins▼xtherapeutic use.▲ |
650 | 2 | 2 | ▼aHistory, 20th Century.▲ |
650 | 2 | 2 | ▼aHistory, 21st Century.▲ |
999 | ▼a경동욱▼c김미선▲ |
![](https://lib.pusan.ac.kr/wp-content/themes/pnul2022/assets/images/default/default_w_279X393.png)
Treating life-threatening bleedings :development of recombinant coagulation factor VIIa
자료유형
국외단행본
서명/책임사항
Treating life-threatening bleedings : development of recombinant coagulation factor VIIa / Ulla K. E. Hedner.
개인저자
Hedner, U. (Ulla)
발행사항
London : Academic Press , 2017.
형태사항
xiv, 199 p. : ill., ports. ; 23 cm.
서지주기
Includes bibliographical references and index.
내용주기
Classical bleeding disease -- My encounter with hemophilia -- The first years at novo nordisk -- The development of recombinant FVIIa -- The futher use and development of rFVIIa -- Legal issues regarding the use of rFVIIa in hemophilia patients with inhibitors -- Treatment with rFVIIa in Malmö --Mechanism of action and dosage -- The continued development of rFVIIa during the 2000s -- Three different descriptions of how rFVIIa was developed -- Some final remarks.
주제
ISBN
9780128124390 (pbk.) 0128124393 (pbk.)
청구기호
612.115 H455t
소장정보
예도서예약
서서가에없는책 신고
보보존서고신청
캠캠퍼스대출
우우선정리신청
배자료배달신청
문문자발송
출청구기호출력
학소장학술지 원문서비스
등록번호 | 청구기호 | 소장처 | 도서상태 | 반납예정일 | 서비스 |
---|
북토크
자유롭게 책을 읽고
느낀점을 적어주세요
글쓰기
느낀점을 적어주세요
청구기호 브라우징
관련 인기대출 도서